New and emerging biologic therapies for moderate‐to‐severe plaque psoriasis: mechanistic rationales and recent clinical data for IL‐17 and IL‐23 inhibitors

Publisher： John Wiley & Sons Inc

E-ISSN： 1529-8019|28|4|179-193

ISSN： 1396-0296

Source： DERMATOLOGIC THERAPY, Vol.28, Iss.4, 2015-07, pp. : 179-193

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevalence of metabolic syndrome in children with moderate to severe psoriasis treated with TNF inhibitors in comparison to conventional agents

By  

DERMATOLOGIC THERAPY, Vol. 31, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effectiveness of a vocabulary data file, encyclopaedia, and Internet homepages in a conversation-support system for people with moderate-to-severe aphasia

By Yasuda Kiyoshi   Nemoto Tatsuya   Takenaka Keisuke   Mitachi Mami   Kuwabara Kazuhiro  

Aphasiology, Vol. 21, Iss. 9, 2007-09 ,pp. : 867-882

Routledge Ltd

Access to resources Recommend Favorite

Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis

By Ishizu Takaaki  

Brain, Vol. 128, Iss. 5, 2005-05 ,pp. : 988-1002

Oxford University Press

Access to resources Recommend Favorite

Review of Biologic Therapies

By Tehrani Rodney   Ostrowski Rochella A   Hariman Richard   Jay Walter M.  

Neuro-Ophthalmology, Vol. 33, Iss. 6, 2009-12 ,pp. : 286-299

Informa Healthcare

Access to resources Recommend Favorite

Effects of levodopa on cognitive functioning in moderate-to-severe Parkinson’s disease (MSPD)

By Morrison C. E.   Borod J. C.   Brin M. F.   Hälbig T. D.   Olanow C. W.  

Journal of Neural Transmission, Vol. 111, Iss. 10-11, 2004-10 ,pp. : 1333-1341

Springer Publishing Company

Access to resources Recommend Favorite